HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication, Clin Infect Dis Off Publ Infect Dis Soc Am, vol.41, issue.7, pp.1053-1059, 2005. ,
Elite control of HIV Infection: implications for vaccines and treatment, Top HIV Med Publ Int AIDS Soc USA, vol.15, issue.4, pp.134-140, 2007. ,
,
57 and plasma HIV RNA levels contribute to the HIV-specific CD8+ T cell response in HIV controllers, J Virol, vol.88, issue.1, pp.176-87, 2014. ,
Restriction of HIV-1 replication in macrophages and CD4+ T cells from HIV controllers, Blood, vol.118, issue.4, pp.955-64, 2011. ,
Public T cell receptors confer high-avidity CD4 responses to HIV controllers, J Clin Invest, vol.126, issue.6, pp.2093-108, 201601. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01319968
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society-USA Panel, JAMA, vol.316, issue.2, pp.191-210, 2016. ,
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults, Recommendations of the International Antiviral Society-USA Panel. JAMA, vol.320, issue.4, pp.379-96, 2018. ,
A systematic review of definitions of extreme phenotypes of HIV control and progression, AIDS Lond Engl, vol.28, issue.2, pp.149-62, 2014. ,
Spontaneous control of viral load and CD4 cell count progression among HIV-1 seroconverters, AIDS Lond Engl, vol.19, issue.17, pp.2001-2008, 2005. ,
,
, superinfection despite broad CD8+ T-cell responses containing replication of the primary virus, Nature, vol.420, issue.6914, pp.434-443, 2002.
Evolution of HIV-1 in an HLA-B*57-positive patient during virologic escape, J Infect Dis, vol.196, issue.1, pp.50-55, 2007. ,
Impact of CD4 and CD8 dynamics and viral rebounds on loss of virological control in HIV controllers, PloS One, vol.12, issue.4, p.173893, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01522520
Demographics and natural history of HIV-1-infected spontaneous controllers of viremia, AIDS Lond Engl, vol.31, issue.8, pp.1091-1099, 201715. ,
Natural history of HIV-control since seroconversion, AIDS Lond Engl, vol.27, issue.15, pp.2451-60, 2013. ,
Comparison of HIV DNA and RNA in gut-associated lymphoid tissue of HIV-infected controllers and noncontrollers, AIDS Lond Engl, vol.27, issue.14, pp.2255-60, 2013. ,
Multiple Origins of Virus Persistence during Natural Control of HIV Infection, Cell, vol.166, issue.4, pp.1004-1019, 2016. ,
Detectable HIV-RNA in semen of HIV controllers, PloS One, vol.12, issue.8, p.183376, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01581747
Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group, N Engl J Med, vol.342, issue.13, pp.921-930, 2000. ,
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort study, Lancet HIV, vol.2, issue.3, pp.98-106, 2015. ,
CD4 dynamics over a 15 year-period among HIV controllers enrolled in the ANRS French observatory, PloS One, vol.6, issue.4, p.18726, 2011. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01420582
Disease Progression in HIV-1-Infected Viremic Controllers, J Acquir Immune Defic Syndr, vol.61, issue.4, pp.407-423, 1999. ,
Clinical outcomes of elite controllers, viremic controllers, and long-term nonprogressors in the US Department of Defense HIV natural history study, J Infect Dis, issue.11, pp.1714-1737, 0200. ,
Rate and predictors of progression in elite and viremic HIV-1 controllers, AIDS Lond Engl, vol.30, issue.8, pp.1209-1229, 2016. ,
Immunologic and Virologic Progression in HIV Controllers: The Role of Viral "Blips" and Immune Activation in the ANRS CO21 CODEX Study, PloS One, vol.10, issue.7, p.131922, 2015. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01415218
Cancers in elite controllers: appropriate follow-up is essential, AIDS Lond Engl, vol.30, issue.11, pp.1852-1857, 201617. ,
Cancer risk in HIV-infected patients: elite controllers are also concerned, AIDS Lond Engl, vol.32, issue.5, pp.673-678, 2018. ,
Rate and predictors of non-AIDS events in a cohort of HIV-infected patients with a CD4 T cell count above 500 cells/mm 3, AIDS Res Hum Retroviruses, vol.29, issue.8, pp.1161-1168, 2013. ,
Analysis of Non-AIDS-Defining Events in HIV Controllers, Clin Infect Dis Off Publ Infect Dis Soc Am, vol.62, issue.10, pp.1304-1313, 2016. ,
,
, Hospitalization Rates and Reasons Among HIV Elite Controllers and Persons With Medically Controlled HIV Infection, J Infect Dis, vol.211, issue.11, pp.1692-702, 2015.
Hospitalizations among HIV controllers and persons with medically controlled HIV in the U.S. Military HIV Natural History Study, J Int AIDS Soc, vol.19, issue.1, p.20524, 2016. ,
Longterm follow-up of elite controllers: Higher risk of complications with HCV coinfection, no association with HIV disease progression, Medicine, vol.96, issue.26, p.7348, 2017. ,
Cardiovascular events in the French ANRS HIV controller cohort, J Acquir Immune Defic Syndr, 1999. ,
Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis, AIDS Lond Engl, vol.23, issue.9, pp.1059-67, 2009. ,
Increased coronary atherosclerosis and immune activation in HIV-1 elite controllers, AIDS Lond Engl, vol.26, issue.18, pp.2409-2421, 2012. ,
Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation, J Am Heart Assoc, vol.3, issue.3, p.844, 2014. ,
Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy, J Infect Dis, vol.197, issue.1, pp.126-159, 2008. ,
Persistent lowlevel viremia in HIV-1 elite controllers and relationship to immunologic parameters, J Infect Dis, vol.200, issue.6, pp.984-90, 2009. ,
Microbial translocation is a cause of systemic immune activation in chronic HIV infection, Nat Med, vol.12, issue.12, pp.1365-71, 2006. ,
,
, Elevated IP10 levels are associated with immune activation and low CD4 + T-cell counts in HIV controller patients, AIDS Lond Engl, vol.28, issue.4, pp.467-76, 2014.
Evidence for innate immune system activation in HIV type 1-infected elite controllers, J Infect Dis, vol.209, issue.6, pp.931-940, 2014. ,
,
, Factors Leading to the Loss of Natural Elite Control of HIV-1 Infection, J Virol, 2017.
Spontaneous control of HIV replication, but not HAART-induced viral suppression, is associated with lower activation of immune cells, J Acquir Immune Defic Syndr, vol.66, issue.4, pp.365-374, 1999. ,
Spontaneous HIV Controllers Exhibit Preserved Immune Parameters in Peripheral Blood and Gastrointestinal Mucosa, J Acquir Immune Defic Syndr, vol.70, issue.2, pp.115-136, 1999. ,
Normal T-cell activation in elite controllers with preserved CD4+ T-cell counts, AIDS Lond Engl, vol.29, issue.17, pp.2245-54, 2015. ,
HIV controllers with different viral load cutoff levels have distinct virologic and immunologic profiles, J Acquir Immune Defic Syndr, vol.68, issue.4, pp.377-85, 1999. ,
,
, CD4 T cell count reconstitution in HIV controllers after highly active antiretroviral therapy, Clin Infect Dis Off Publ Infect Dis Soc Am, vol.50, issue.8, pp.1187-91, 2010.
T cell dynamics and the response to HAART in a cohort of HIV-1-infected elite suppressors, Clin Infect Dis Off Publ Infect Dis Soc Am, vol.49, issue.11, pp.1763-1769, 2009. ,
Effect of antiretroviral therapy on HIV reservoirs in elite controllers, J Infect Dis, vol.208, issue.9, pp.1443-1450, 2013. ,
Antiretroviral therapy in HIV-infected elite controllers: impact on gut immunology, microbial translocation, and biomarkers of serious non-AIDS conditions, J Acquir Immune Defic Syndr, vol.67, issue.5, pp.514-522, 1999. ,
Prospective antiretroviral treatment of asymptomatic, HIV-1 infected controllers, PLoS Pathog, vol.9, issue.10, p.1003691, 2013. ,
Blunted response to combination antiretroviral therapy in HIV elite controllers: an international HIV controller collaboration, PloS One, vol.9, issue.1, p.85516, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01344809
ART reduces T cell activation and immune exhaustion markers in HIV controllers, Clin Infect Dis Off Publ Infect Dis Soc Am, 2019. ,
A Subset of Extreme Human Immunodeficiency Virus (HIV) Controllers Is Characterized by a Small HIV Blood Reservoir and a Weak T-Cell Activation Level, Open Forum Infect Dis, vol.4, issue.2, p.64, 2017. ,
Early control of HIV-1 infection in long-term nonprogressors followed since diagnosis in the ANRS SEROCO/HEMOCO cohort, J Acquir Immune Defic Syndr, vol.50, issue.1, pp.19-26, 1999. ,
,
, Comprehensive analysis of unique cases with extraordinary control over HIV replication, Blood, vol.119, issue.20, pp.4645-55, 2012.
Dynamics in HIV-DNA levels over time in HIV controllers, J Int AIDS Soc, vol.22, issue.1, p.25221, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02024787
Rapid Quantification of the Latent Reservoir for HIV-1 Using a Viral Outgrowth Assay, PLoS Pathog, vol.9, issue.5, 2013. ,
CROI 2019: advances in antiretroviral therapy, Top Antivir Med, vol.27, issue.1, pp.50-68, 2019. ,
,
, Hydroxychloroquine drastically reduces immune activation in HIV-infected, antiretroviral therapy-treated immunologic nonresponders, Blood, vol.118, issue.12, pp.3263-72, 2011.
Significant Decrease in Plasma Levels of D-Dimer, Interleukin-8, and Interleukin-12 After a 12-Month Treatment with Rosuvastatin in HIV-Infected Patients Under Antiretroviral Therapy, AIDS Res Hum Retroviruses, vol.33, issue.2, pp.126-158, 2017. ,